Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 21 EP applications Bernd Hutter has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11791636

NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF

IPC classification:
C07K 7/14
Agent:
Bernd Hutter, MorphoSys AG
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Status:
PATENT GRANTED
EP11790968

SIMULTANEOUS DETECTION OF BIOMOLECULES IN SINGLE CELLS

IPC classification:
G01N 33/68, G01N 33/569, G01N 33/543, C12Q 1/68
Applicant:
MorphoSys AG
Applicant:
University of Freiburg (Albert-Ludwigs-Universität Freiburg)
Agent:
Sven Lange, Hertin und Partner Rechts- und Patentanwälte PartG mbB
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12733779

ANTIBODIES THAT ARE CROSS-REACTIVE FOR MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) AND D-DOPACHROME TAUTOMERASE (D-DT)

IPC classification:
C07K 16/40, C07K 16/24
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
GRANT OF PATENT INTENDED
EP12735555

USE OF C-FMS ANTAGONISTS

IPC classification:
A61K 39/395, C07K 16/24, A61P 25/04, A61P 19/02
Applicant:
University of Melbourne
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
PATENT GRANTED
EP11785411

A COLLECTION AND METHODS FOR ITS USE

IPC classification:
C12N 15/10, C07K 16/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12747923

COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12745883

COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A PURINE ANALOG

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP12775247

ANTAGONISTS OF IL17C FOR THE TREATMENT OF INFLAMMATORY DISORDERS

IPC classification:
C07K 16/24, A61P 29/00, A61P 19/02, A61P 11/00
Applicant:
Galapagos NV
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
The patent has been granted
EP14164595

Generation and profiling of fully human HuCAL GOLD(RTM)-derived therapeutic antibodies specific for human CD38

IPC classification:
C07K 16/28, A61P 35/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Agent:
Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13700913

USE OF LYSOZYME AS A TAG

IPC classification:
C12N 15/62, C07K 1/22
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13752873

COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE

IPC classification:
G01N 33/564, G01N 33/53, C07K 16/24, C07K 16/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP13766523

COMBINATIONS AND USES THEREOF

IPC classification:
A61K 39/395, A61K 31/195, C07K 16/28, A61P 35/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
The patent has been granted
EP13788728

RADIOLABELLED ANTIBODY AND USES THEREOF

IPC classification:
A61K 51/10, A61P 35/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
PATENT GRANTED
EP15151492

Anti-CD38 human antibodies and uses therefor

IPC classification:
C07K 16/28, A61P 37/00
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP13815739

ANTI-STAPHYLOCOCCAL ANTIBODIES

IPC classification:
C07K 16/12
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
GRANT OF PATENT INTENDED
EP14720512

ANTIBODIES TARGETING M-CSF

IPC classification:
C07K 16/24
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION IN PROGRESS
EP14718555

ANTIBODIES TARGETING SPECIFICALLY HUMAN CXCR2

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION REQUESTED
EP11761360

ANTI-CD38 ANTIBODY AND LENALIDOMIDE OR BORTEZOMIB FOR THE TREATMENT OF MULTIPLE MYELOMA AND NHL

IPC classification:
A61K 31/69, A61P 35/00, C07K 16/28, C07K 16/30, A61K 31/454, A61K 45/06, A61K 38/07, A61K 38/05, A61K 39/395
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Agent:
Olga Bezzubova, Jones Day
Status:
PATENT GRANTED
EP15720692

PEPTIDE LIBRARIES

IPC classification:
C40B 40/10, G01N 33/53, C12N 15/10, C07K 1/04
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
EXAMINATION REQUESTED
EP17193089

GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38

IPC classification:
G01N 33/574, A61P 35/00, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
Request for examination was made
EP16723349

TREATMENT FOR MULTIPLE MYELOMA (MM)

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Bernd Hutter, MorphoSys AG
Status:
Request for examination was made

Please Sign in to use this feature